Stockscreener 앱 받기
3.87
0.52%
0.02
시간 외 거래:
3.85
-0.02
-0.52%
전일 마감가:
$3.85
열려 있는:
$3.9
하루 거래량:
270.85K
Relative Volume:
1.24
시가총액:
$231.74M
수익:
$32.72M
순이익/손실:
$-54.64M
주가수익비율:
-3.4318
EPS:
-1.1277
순현금흐름:
$-55.08M
1주 성능:
-3.73%
1개월 성능:
+4.03%
6개월 성능:
-10.00%
1년 성능:
+15.18%
1일 변동 폭
$3.84
$4.005
1주일 범위
$3.84
$4.17
52주 변동 폭
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.87 | 237.73M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 개시 | TD Cowen | Buy |
| 2025-08-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-03-20 | 개시 | BTIG Research | Buy |
| 2025-01-02 | 개시 | Barclays | Overweight |
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Recognition Risk - newsline.com
Orchestra BioMed (OBIO) Edges Higher, Testing Key Resistance Zone on Modest VolumeLow Beta Factor - newsline.com
Orchestra BioMed (NASDAQ: OBIO) CFO has shares withheld to cover RSU tax obligations - Stock Titan
Orchestra BioMed (OBIO) insider uses 6,566 shares to cover RSU taxes - Stock Titan
Orchestra BioMed Grants Equity Awards to New Employees - MyChesCo
Number of shareholders of Orchestra BioMed Holdings, Inc. – NASDAQ:OBIO - TradingView
Orchestra BioMed Holdings (OBIO) Slips 2.26% as Shares Test Support Near $3.70Chart Pattern Alerts - newsline.com
Orchestra BioMed receives $20 million from Medtronic - Investing.com
OBIO: Upcoming BackBeat and Virtue trial milestones signal strong growth and partnership-driven value - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra Bio - GuruFocus
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra BioMed Holdings Inc (OBIO) - GuruFocus
Orchestra BioMed (OBIO) director adds 5,000 shares in open-market buy - Stock Titan
Orchestra BioMed (OBIO) director Darren Sherman sells 15,000 shares under 10b5-1 plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Affiliate sale notice: OBIO (NASDAQ: OBIO) proposes sale of 15,000 shares - Stock Titan
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss as Company Advances PipelineAnnual Report - newsline.com
Orchestra BioMed Holdings (OBIO) Slides 1.76% as Shares Test Key Support LevelsIron Condor Alert - thelegaladvocate.com
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss Fuels Optimism Amid Pre-Revenue StageHigh Growth Earnings - newsline.com
Orchestra BioMed (OBIO) CFO has 3,076 RSU shares withheld for taxes - Stock Titan
Orchestra BioMed (OBIO) insider reports RSU tax-withholding of 4,925 shares - Stock Titan
OBIO Q1 2026 Earnings: Loss Narrows More Than Expected, Stock Modestly DeclinesAnnual Earnings Summary - newsline.com
Orchestra BioMed (OBIO) Edges Higher: Navigating Key Support and Resistance LevelsPullback Trade - The Legal Advocate
OBIO Q1 2026 Earnings: EPS Beat Narrowed Losses, But No Revenue YetStrong Earnings Momentum - The Legal Advocate
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline in Pre-Revenue Phase - Newser
Orchestra BioMed Holdings (OBIO) Slips Slightly as Stock Hovers Near SupportBreakaway Gap - newsline.com
OBIO Q1 2026 Earnings: Narrowed Loss as EPS Surpasses Estimates; Stock Posts Modest DeclineLong-Term Guidance - Newser
Orchestra BioMed Advances FDA Path for Hypertension Device - MyChesCo
Orchestra BioMed Targets 2027 Data for Hypertension Trial - MyChesCo
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock - Yahoo Finance
Orchestra BioMed director Jason buys $2,493 in stock - Investing.com UK
Orchestra BioMed director Jason buys $2,493 in stock By Investing.com - Investing.com Canada
Orchestra BioMed (OBIO) director adds 665 shares in open-market buy - Stock Titan
Orchestra BioMed Holdings (OBIO) price target increased by 11.30% to 12.68 - MSN
Orchestra BioMed CEO David Hochman buys $18,850 in company stock By Investing.com - Investing.com Nigeria
Orchestra BioMed director Aryeh Jason buys $34,986 in stock By Investing.com - Investing.com Nigeria
Orchestra BioMed director Aryeh Jason buys $34,986 in stock - Investing.com India
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire
Orchestra BioMed CEO David Hochman buys $18,850 in company stock - Investing.com
Director at Orchestra BioMed (OBIO) buys 8,971 shares in open market - Stock Titan
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating - marketscreener.com
Orchestra BioMed director Fain buys $82,600 in shares By Investing.com - Investing.com South Africa
Orchestra BioMed director Fain buys $82,600 in shares - Investing.com UK
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orchestra Biomed Holdings Inc 주식 (OBIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sherman Darren | See Remarks |
Jun 01 '26 |
Sale |
3.87 |
15,000 |
58,050 |
1,184,327 |
2.60%
0.94%
자본화:
|
볼륨(24시간):